Clinicopathologic and molecular spectrum of gastrointestinal stromal tumor (GIST) with NTRK fusion and marked response to larotrectinib in GIST with NTRK fusion: a case report
Cellular Oncology · 2026
DOI: 10.1007/s13402-025-01146-6 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cellular Oncology, 2026. Verfasst von Yanying Shen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 1630 Dongfang Road, Shanghai, 200127, China. Hauptthemen laut MEDLINE: Gastrointestinal Stromal Tumors, Pyrimidines, Oncogene Proteins, Fusion, Pyrazoles. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 1630 Dongfang Road, Shanghai, 200127, China.
- Department of Gastrointestinal Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Department of Pathology, Beth Israel Deaconess Medical Center, Harvard medical school, Boston, MA, 02215, USA.
- Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
- Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. laq12306@rjh.com.cn.
- Department of Gastrointestinal Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. wangming1882@hotmail.com.
Förderung
- NCI NIH HHS
- National Natural Science Foundation of China
Zitieren
APA
Shen, Y., Peng, Q., Wen, J., Yang, L., Zhu, L., Chen, Y., Liu, Q., Wang, L., Yao, J., Li, A., Wang, M., & Liu, Z. (2026). Clinicopathologic and molecular spectrum of gastrointestinal stromal tumor (GIST) with NTRK fusion and marked response to larotrectinib in GIST with NTRK fusion: a case report. Cellular Oncology. https://doi.org/10.1007/s13402-025-01146-6
Vancouver
Shen Y, Peng Q, Wen J, Yang L, Zhu L, Chen Y, et al. Clinicopathologic and molecular spectrum of gastrointestinal stromal tumor (GIST) with NTRK fusion and marked response to larotrectinib in GIST with NTRK fusion: a case report. Cellular Oncology. 2026. doi:10.1007/s13402-025-01146-6
BibTeX
@article{Shen2026,
author = {Shen, Yanying and Peng, Qi and Wen, Jinxuan and Yang, Linxi and Zhu, Lingyan and Chen, Yiming and Liu, Qiang and Wang, Lisha and Yao, Jinjuan and Li, Anqi and Wang, Ming and Liu, Zebing},
title = {Clinicopathologic and molecular spectrum of gastrointestinal stromal tumor (GIST) with NTRK fusion and marked response to larotrectinib in GIST with NTRK fusion: a case report},
journal = {Cellular Oncology},
year = {2026},
doi = {10.1007/s13402-025-01146-6}
}
EUVIMED